Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Acute Otitis Media in Children Younger Than 2 Years

Acute Otitis Media in Children Younger Than 2 Years Letters Critical revision of the manuscript for important intellectual content: Mendelson, Results | The established i2b2 platform retrieved deidentified Zachariah, de Ferranti, Bickel. information for 68 patients in Preventive Cardiology pre- Statistical analysis: Mendelson. scribed atorvastatin among the approximately 1800 patients Administrative, technical, or material support: Mendelson, Zachariah, Bickel. seen during the 2-year search period. After reidentification Study supervision: Zachariah, de Ferranti. and EHR review, 14 patients (21%) were found to be no lon- Conflict of Interest Disclosures: None reported. ger taking atorvastatin. We completed targeted telephone Funding/Support: This work was supported by the National Institutes of calls and mailouts by December 6, 2012, approximately 1 Health Office of the Director, National Library of Medicine, and National Institute of General Medical Sciences grant 2U54LM008748 (i2b2 [Informatics week after the FDA notification. Among patients reached by for Integrating Biology & Bedside]), National Heart, Lung, and Blood Institute telephone, only 36% (10 of 28) had heard about the recall grant 1K23HL111335 (Dr Zachariah), and the New Balance Obesity Treatment from media reports or other sources. Overall, the team of and Prevention Foundation (Dr de Ferranti). physicians, a nurse practitioner, and a nurse reported that Role of the Sponsors: None of the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Pediatrics American Medical Association

Acute Otitis Media in Children Younger Than 2 Years

Loading next page...
 
/lp/american-medical-association/acute-otitis-media-in-children-younger-than-2-years-Yk3b9FxQ6N
Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6203
eISSN
2168-6211
DOI
10.1001/jamapediatrics.2013.3068
pmid
23999574
Publisher site
See Article on Publisher Site

Abstract

Letters Critical revision of the manuscript for important intellectual content: Mendelson, Results | The established i2b2 platform retrieved deidentified Zachariah, de Ferranti, Bickel. information for 68 patients in Preventive Cardiology pre- Statistical analysis: Mendelson. scribed atorvastatin among the approximately 1800 patients Administrative, technical, or material support: Mendelson, Zachariah, Bickel. seen during the 2-year search period. After reidentification Study supervision: Zachariah, de Ferranti. and EHR review, 14 patients (21%) were found to be no lon- Conflict of Interest Disclosures: None reported. ger taking atorvastatin. We completed targeted telephone Funding/Support: This work was supported by the National Institutes of calls and mailouts by December 6, 2012, approximately 1 Health Office of the Director, National Library of Medicine, and National Institute of General Medical Sciences grant 2U54LM008748 (i2b2 [Informatics week after the FDA notification. Among patients reached by for Integrating Biology & Bedside]), National Heart, Lung, and Blood Institute telephone, only 36% (10 of 28) had heard about the recall grant 1K23HL111335 (Dr Zachariah), and the New Balance Obesity Treatment from media reports or other sources. Overall, the team of and Prevention Foundation (Dr de Ferranti). physicians, a nurse practitioner, and a nurse reported that Role of the Sponsors: None of the

Journal

JAMA PediatricsAmerican Medical Association

Published: Dec 1, 2013

References